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EDITORIAL
Maternal  and  neonatal  mortality:  time  to act,
Mortalidade  materna  e  neonatal:  hora  de  agir
Waldemar A. Carlo ∗, Colm P. TraversUniversity  of  Alabama  at  Birmingham,  Division  of  Neonatology,  Birmingham,  United  States
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cMaternal,  infant,  and  neonatal  mortality  rate  are  bench-
marks  for  maternal/infant  care  and  the  health  of  a  society
in  general.  Global  efforts  to  reduce  these  mortality  rates
have  been  led  by  the  World  Health  Organization  (WHO)
and  the  United  Nations;  the  rates  have  decreased  substan-
tially  worldwide,  but  the  ambitious  reductions  set  forth  by
the  Millennium  Development  Goals  have  not  been  achieved.
Maternal  mortality  has  decreased  by  approximately  45%
from  the  Millennium  Development  Goals  baseline  rate  in
1990.1 One  in  four  babies  worldwide  are  delivered  with-
out  the  presence  of  a  skilled  birth  attendant.  Every  day,
hundreds  of  preventable  maternal  deaths  occur  due  to  preg-
nancy  or  childbirth-related  complications.  Infant  mortality
rates  have  decreased  in  developing  countries,  but  these
reductions  have  been  largely  due  to  decreases  in  deaths
from  pneumonia  and  diarrheal  disease  after  the  neonatal
period,  while  earlier  deaths  relating  to  prematurity,  birth
asphyxia,  and  infection  have  experienced  a  lower  decrease.2
As  a  consequence,  neonatal  deaths  now  account  for  44%
of  the  childhood  mortality,  the  highest  rate  ever.2 Approxi-
mately  2.8  million  babies  worldwide  die  each  year  during  the
ﬁrst  month  after  birth;  most  of  these  deaths  occur  in  devel-
oping  countries.2 Scaling  up  interventions  proven  to  be  very
effective  could  substantially  reduce  the  regrettable  loss  of
young  lives.
 Please cite this article as: Carlo WA, Travers CP. Maternal and
neonatal mortality: time to act. J Pediatr (Rio J). 2016;92:543--5.
 See paper by Rodrigues et al. in pages 567--73.
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the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nThe  article  ‘‘Temporal  and  spatial  evolution  of  mater-
al  and  neonatal  mortality  rates  in  Brazil,  1997--2012,’’  by
odrigues  et  al.3 reports  the  trends  in  maternal  mortality
atio  and  neonatal  mortality  rate  in  a  large  geographical
rea  with  signiﬁcant  disparities  in  socioeconomic  status.  The
tudy  highlights  that  the  maternal  mortality  rate  remained
elatively  constant  during  the  study  period  in  spite  of
ecreases  in  the  neonatal  mortality  rate.  Furthermore,
mportant  geospatial  differences  in  mortality  were  docu-
ented;  the  largest  reductions  in  neonatal  mortality  rates
ere  observed  in  regions  with  the  highest  socioeconomic
tatus,  when  compared  to  regions  with  the  lowest  socio-
conomic  status  in  Brazil.  International  comparisons  of  the
eonatal  mortality  rate  are  difﬁcult  to  interpret  due  to
ajor  differences  in  reporting,  as  infants  at  the  lowest  birth
eights  and  gestation  ages  may  be  counted  as  fetal  deaths
egardless  of  signs  of  life  after  birth.4,5
Efforts  related  to  the  Millennium  Development  Goals
ave  been  associated  with  a reduction  of  approximately
5%  in  maternal  mortality  and  over  50%  in  neonatal  and
hild  mortality.  The  reduction  in  neonatal  and  child  mor-
ality  has  resulted  in  almost  six  million  lives  saved  per  year.
owever,  similar  to  the  results  from  Brazil  in  the  study  by
odrigues  et  al.3 these  reductions  in  maternal  and  neonatal
ortality  have  not  been  homogeneous,  with  smaller  reduc-
ions  or  even  increases  in  the  most  vulnerable  populations.
ost  maternal,  neonatal,  and  child  deaths  are  preventable
ith  implementation  of  well-proven  and  effective  health-
are  interventions.Thus,  what  can  be  done  to  reduce  neonatal  and  mater-
al  mortality?  The  ﬁrst  two  days  after  birth  account  for  over
0%  of  neonatal  deaths,  while  the  ﬁrst  week  of  life  accounts
or  over  75%  of  all  neonatal  deaths.  Neonatal  deaths  are
dade Brasileira de Pediatria. This is an open access article under
d/4.0/).
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ost  frequently  due  to  birth  asphyxia,  prematurity,  sepsis,
nd  congenital  malformation,  indicating  that  interventions
hould  focus  on  during  labor  and  the  early  post-natal  period,
ased  on  the  timing  of  the  causes  of  death,  with  some
fforts  to  reduce  neonatal  deaths  extended  beyond  the
rst  week  after  birth.  Therefore,  the  WHO  has  made  a
trong  recommendation  for  postnatal  care  in  facilities  for
t  least  24  h  after  birth  and  postnatal  contact  within  24  h
fter  birth  for  infants  born  at  home.6 Training  in  resusci-
ation  and  in  essential  newborn  care  reduces  perinatal  and
eonatal  mortality.5,7 It  has  been  estimated  that  these  pro-
rams  have  the  potential  to  reduce  up  to  a  million  deaths
er  year  if  implemented  worldwide.8 The  Helping  Babies
reathe  and  the  Essential  Care  for  Every  Baby  training  pro-
rams  are  available,  but  have  not  been  scaled  up  as  needed.
he  new  program  Essential  Care  for  Small  Babies  also  has
he  potential  to  reduce  deaths  due  to  prematurity,  the  cur-
ent  main  cause  of  infant  mortality.  These  programs  can
e  implemented  in  such  a  way  to  be  one  of  the  most
ost-effective  interventions  to  reduce  neonatal  mortality.9
n  addition,  postnatal  contacts  are  recommended  on  the
hird  day  (48--72  h),  between  the  seventh  and  14th  day,
nd  six  weeks  after  birth.  Public  health  initiatives  that
im  to  improve  access  to  health  care  and  target  those  at
ighest  risk  of  adverse  outcomes  can  reduce  maternal  and
eonatal  mortality.  Such  interventions  include  home  visits
y  community  health  workers,  especially  in  selected  high
ortality  settings.  Home  visits  for  neonatal  care  by  commu-
ity  health  workers  are  associated  with  reduced  neonatal
ortality  in  resource-limited  settings  with  poorly  accessi-
le  facility-based  healthcare.  Trained  healthcare  workers
an  identify  seriously  ill  children.  Data  from  several  con-
rolled  studies  in  settings  of  poor  access  to  facility-based
ealthcare  in  South  Asia  indicate  that  home-based  neonatal
are  through  community  healthcare  workers  reduced  neona-
al  and  perinatal  mortality,  particularly  in  those  settings
ith  the  highest  baseline  neonatal  mortality  rates.10 The
doption  of  this  policy  is  justiﬁed  in  such  settings.
There  is  a  large  body  of  evidence  on  effective  health-
are  packages  of  selective  low-cost  effective  interventions
o  reduce  neonatal  mortality  in  resource-limited  settings
n  low-  and  middle-income  settings,  which  are  particularly
ppropriate  for  scaling  up.11 Large  scale  trials  have  demon-
trated  the  feasibility  and  effectiveness  of  packages  of
nterventions  to  reduce  neonatal  mortality.5,11 In  the  recent
very  Newborn  series  by  Lancet,  it  has  been  estimated  that
ery  large  neonatal  survival  beneﬁts  would  accrue  from
caling  up  interventions  consisting  of  healthcare  packages
articularly  focused  on  small  and  sick  neonates.5,11 In  that
ight,  the  WHO  recommendations6 based  on  these  reviews
rovide  an  opportune  policy  impetus  toward  achieving  the
ost-2015  neonatal  mortality  targets.
Neonatal  hypothermia  occurs  in  as  many  as  50%  of
nfants  in  low-  and  middle-income  settings;  the  severity  of
ypothermia  is  associated  with  a  higher  risk  of  mortality
uring  the  ﬁrst  seven  days  after  birth.12 To  reduce  neonatal
ypothermia,  the  WHO  recommends  a  set  of  interlinked  pro-
edures  called  the  ‘‘warm  chain’’  to  be  followed  after  birth.
nterventions  include  warm  delivery  rooms,  immediate  dry-
ng,  skin-to-skin  contact  as  continuously  as  possible,  early
reastfeeding,  delayed  bathing  and  weighing,  appropriate
undling  of  mother  and  baby  together,  warm  transportation,
s
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arm  resuscitation,  along  with  training  and  raising  aware-
ess  of  the  risks  of  hypothermia.  Kangaroo  mother  care,
 method  of  skin-to-skin  contact,  promotes  breastfeeding,
educes  hypothermia,  neonatal  mortality,  sepsis,  and  length
f  hospital  stay  at  discharge  or  at  40  weeks  in  preterm  and
ow  birth  weigh  infants  compared  to  conventional  hospital
are.13 Multiple  applications  (daily  for  seven  to  ten  days)
f  chlorhexidine  to  the  umbilical  cord  can  reduce  the  risk  of
eonatal  mortality  and  omphalitis  in  infants  born  at  home  in
igh  neonatal  mortality  settings  (30  or  more  neonatal  deaths
er  1000  live  births),14 and  is  recommended  by  WHO.  How-
ver,  there  is  insufﬁcient  evidence  for  recommending  this
ntervention  in  infants  born  in  health  facilities  and/or  lower
eonatal  mortality  settings.  Observational  studies  suggest
hat  hospital  mortality  in  preterm  infants  could  be  reduced
ith  implementation  of  continuous  positive  airway  pressure,
hich  is  consistent  with  data  from  randomized  controlled
rials  conducted  in  high-resource  settings.15 Evidence  from
andomized  and  observational  studies  indicates  that  rou-
ine  intramuscular  administration  of  1  mg  of  vitamin  K  at
irth  reduces  vitamin  K  deﬁciency  bleeding  during  infancy.16
xtensive  evidence  from  high  income  settings  indicate  that
urfactant  replacement  therapy  reduces  mortality  and  air
eaks;17 surfactant  therapy  has  the  potential  to  reduce
eonatal  mortality  and  air  leaks  in  low-resource  settings.
ome  studies  in  low-resource  settings  that  tested  therapies
ith  proven  efﬁcacy  in  high-resource  settings  have  had  dis-
ppointing  results.  For  example,  a  large  cluster-randomized
ontrolled  trial  of  antenatal  corticosteroid  administration
n  resource-limited  countries  did  not  observe  a  survival
eneﬁt  among  preterm  infants  exposed  to  antenatal  cor-
icosteroids;  exposure  was  associated  with  an  increased  risk
f  maternal  infection.18
Maternal  mortality  targets  are  not  declining  at  the  rate
et  in  the  Millennium  Development  Goals.  The  maternal
orality  ratio  declined  from  385  deaths  per  100,000  live-
irths  in  1990--216  in  2015,  worldwide,  having  decreased
n  all  WHO  regions.1 The  major  causes  of  maternal  deaths
re  post-partum  hemorrhage,  pre-eclampsia/pregnancy-
nduced  hypertension  and  eclampsia,  and  infections,  all
f  which  are  largely  preventable  with  proven  and  effec-
ive  interventions.  To  date,  successful  strategies  that  have
educed  maternal  mortality  in  low-resource  settings  have
ncluded  investment  in  transportation  and  access  to  care,19
s  well  as  investment  in  antiretroviral  therapy  in  countries
ith  high  prevalence  of  human  immunodeﬁciency  virus
nfection.20 Access  to  maternal  and  child  health  services
as  been  improved  by  opening  health  centers  24  h  per
ay  and  by  adding  maternity  waiting  houses  and  delivery
ooms  at  health  centers.21 Increasing  the  number  of  skilled
irth  attendants  has  also  been  linked  to  reductions  in  the
aternal  mortality  ratio.21 National  training  programs  have
ncreased  the  number  of  midwives  and  trained  community
ealthcare  workers  available,  particularly  in  underserved
reas  through  targeted  deployment  and  incentivization.21
ontinued  research  efforts  and  improved  data  are  needed
o  determine  cost-effective  ways  to  implement  interven-
ions  that  can  reduce  maternal  mortality  in  low-resource
ettings.
In  summary,  as  reported  for  Brazil,  despite  major
eductions  in  mortality,  the  Millennium  Development  Goals
egarding  the  reduction  in  maternal  and  neonatal  mortality
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have  not  been  achieved,  particularly  for  the  most  vulner-
able  populations  worldwide.  Geospatial  and  temporal  data
can  help  identify  the  most  vulnerable  areas  that  are  in  par-
ticular  need  of  improved  maternal  and  neonatal  care.  As
stated  by  Nobel  laurate  Gabriela  Mistral,  ‘‘we  are  guilty  of
many  errors  and  many  faults,  but  our  worst  crime  is  aban-
doning  the  children,  neglecting  the  fountain  of  life.’’  It  is
time  to  act  to  scale  up  interventions  proven  to  be  efﬁcient
and  cost-effective.
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